|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000661543
|
NFKB2
|
DB11672
|
Curcumin
|
epilepsy
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Niaodukang mixture
|
chronic kidney disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
tongue squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
esophageal squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
head and neck cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
thyroid cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
head and neck squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hcc
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
liver cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
cholangiocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
glioblastoma multiforme (gbm)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
salivary adenoid cystic carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
endometrial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
oral cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
tongue squamous cell carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
primary lung adenocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
bladder cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colon cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
oral squamous cell cancer (oscc)
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic ductal adenocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
glioblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
gastrointestinal stromal tumor
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
epithelial ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
cervical cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
malignant melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung adenocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
gastric cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
chondrosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
weri-RB-1 retinoblastoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
ovarian cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
non-small cell lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
glioma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
prostate cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
cholangiocarcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
pancreatic cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
melanoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
nasopharyngeal carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
breast cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
renal cell cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
hepatocellular carcinoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
colorectal cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
astrocytoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
lung cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
osteosarcoma
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
NA
|
endometrial cancer
|
up-regulated
|
predicted
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01220
|
Rifaximin
|
inflammatory bowel disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB11672
|
Curcumin
|
medulloblastoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB16101
|
Baicalein
|
stroke
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB16101
|
Baicalein
|
neurodegenerative disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB03336
|
BIA
|
airway inflammatory disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB04216
|
Quercetin
|
gastritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
BAY11-7082
|
vitiligo
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12422
|
Sulforaphane
|
atherosclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00983
|
Formoterol
|
neuroinflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01407
|
Clenbuterol
|
neuroinflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB15589
|
Zingerone
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Rhynchophylline
|
permanent middle cerebral artery occlusion
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB02656
|
LY-294002
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Saikosaponin d
|
acute liver injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB07080
|
TO-901317
|
autoimmune uveitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB02709
|
Resveratrol
|
ischemic brain injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB07352
|
Apigenin
|
various liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB07352
|
Apigenin
|
sepsis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB07352
|
Apigenin
|
diabetes
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB07352
|
Apigenin
|
atherosclerosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00313
|
Valproic acid
|
alzheimer＇s disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB16607
|
Lithium chloride
|
colorectal cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Neurotropin
|
non-alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB06543
|
Astaxanthin
|
neuroinflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB16921
|
Oxaloacetic acid
|
neurodegenerative disease
|
up-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Flavanol
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
CHIR99021
|
thrombotic disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01944
|
(S)-blebbistatin
|
thrombotic disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Xia-yu-xue decoction
|
liver fibrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Teuclatriol
|
infection
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00656
|
Trazodone
|
neuroinflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01033
|
Mercaptopurine
|
airway disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB04339
|
Carbocisteine
|
chronic obstructive pulmonary disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB16886
|
Tanshinone I
|
parkinson＇s disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12029
|
Chlorogenic Acid
|
acute liver injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12052
|
Icariin
|
cardiac aging
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB14204
|
Nickel cation
|
renal inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB14184
|
Cinnamaldehyde
|
cerebral ischaemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB14184
|
Cinnamaldehyde
|
stroke
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB07080
|
TO-901317
|
retinal disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00412
|
Rosiglitazone
|
peritonitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Astragaloside IV
|
viral myocarditis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Jieduquyuzishen prescription
|
systemic lupus erythematosus
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Gualou Guizhi decoction
|
middle cerebral artery occlusion
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12003
|
Thymosin beta-4
|
periodontitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12003
|
Thymosin beta-4
|
inflammatory osteolytic disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Pseudolaric acid B
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00177
|
Valsartan
|
arrhythmogenesis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Ikargamycin
|
cystic fibrosis
|
up-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Stauntoside B
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
FTI-277
|
septicemia
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Ascofuranone
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB05767
|
Andrographolide
|
periodontal disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB04216
|
Quercetin
|
oral squamous cell carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Vanillin
|
cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12290
|
Puerarin
|
coronary artery disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01039
|
Fenofibrate
|
cerebral hemorrhage
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12116
|
Epigallocatechin gallate
|
alzheimer＇s disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB14154
|
Gold
|
rheumatoid arthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00983
|
Formoterol
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00783
|
Estradiol
|
ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00783
|
Estradiol
|
inflammatory bowel disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00783
|
Estradiol
|
colon cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB12376
|
Ricolinostat
|
acute hepatic failure
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01065
|
Melatonin
|
obesity
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB15588
|
Ursolic acid
|
atherosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01590
|
Everolimus
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Fargesin
|
inflammatory bowel disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00862
|
Vardenafil
|
cholestatic liver damage
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB16599
|
Cerebrolysin
|
cerebral ischemia-reperfusion injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Fucoidan
|
cerebral ischemia-reperfusion injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB17939
|
Pterostilbene
|
obstructive sleep apnea syndrome
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Moshen granule
|
idiopathic membranous nephropathy
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01126
|
Dutasteride
|
bladder cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Dioscin
|
autoimmune thyroiditis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Si-Wu Decoction
|
ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Notoginsenoside
|
brain microcirculation disorder
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Yinhuapinggan granule
|
upper respiratory infection
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Kolaviron
|
type-2 diabetes
|
up-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Colorgrit
|
ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00136
|
|
colon aberrations
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00136
|
Calcitriol
|
colon cancer cell
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB04115
|
Berberine
|
myocardial ischaemia/reperfusion injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB09274
|
Artesunate
|
ulcerative colitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00091
|
Cyclosporine
|
chronic nephrosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Taiwanese green propolis
|
inflammation
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB00482
|
Celecoxib
|
rheumatoid arthritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB09274
|
Artesunate
|
acute kidney injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Shenling baizhu powder
|
rotavirus enteritis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
NA
|
Methyl Brevifolincarboxylate
|
non-alcoholic fatty liver disease
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2
|
DB01656
|
Roflumilast
|
periodontitis
|
down-regulated
|
validated
|
more...
|
|
ENST00000661543
|
NFKB2 (P52)
|
DB00482 (APRD00373)
|
Celecoxib
|
breast cancer
|
down-regulated
|
validated
|
more...
|